Ligand-based CAR design enhances durability of CD70-targeted CAR T cells in glioblastoma.
Saved in:
| Title: | Ligand-based CAR design enhances durability of CD70-targeted CAR T cells in glioblastoma. |
|---|---|
| Authors: | Strassheimer F; Goethe University Frankfurt, University Hospital, Dr. Senckenberg Institute of Neurooncology, Frankfurt, Germany.; Goethe University Frankfurt, Frankfurt Cancer Institute (FCI), Frankfurt, Germany., Steinbach JP; Goethe University Frankfurt, University Hospital, Dr. Senckenberg Institute of Neurooncology, Frankfurt, Germany.; Goethe University Frankfurt, Frankfurt Cancer Institute (FCI), Frankfurt, Germany., Burger MC; Goethe University Frankfurt, University Hospital, Dr. Senckenberg Institute of Neurooncology, Frankfurt, Germany.; Goethe University Frankfurt, Frankfurt Cancer Institute (FCI), Frankfurt, Germany. |
| Source: | Molecular therapy. Oncology [Mol Ther Oncol] 2026 Feb 20; Vol. 34 (1), pp. 201150. Date of Electronic Publication: 2026 Feb 20 (Print Publication: 2026). |
| Publication Type: | News |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918752083706676 Publication Model: eCollection Cited Medium: Print ISSN: 2950-3299 (Print) Linking ISSN: 29503299 NLM ISO Abbreviation: Mol Ther Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2950-3299 |
|---|---|
| DOI: | 10.1016/j.omton.2026.201150 |
